Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MigraPure H is an over‑the‑counter, hemp‑based, all‑natural migraine and headache relief product developed by PuraMed BioScience as an advanced formulation of its sublingual feverfew and ginger gel technology originally clinically tested as LipiGesic M. It combines the bioactive herbal ingredients of MigraPure (feverfew and ginger) with a hemp base, aiming to provide rapid relief of migraine and seizure‑related headaches, and early reports suggest potential benefit in tension and cluster headaches and other epilepsy‑associated symptoms. Delivered sublingually, the formulation is designed to bypass first‑pass hepatic metabolism and achieve fast systemic exposure, and is marketed as non‑drowsy, non‑habit forming, and not associated with rebound headaches.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on MigraPure H.